期刊文献+

蒿甲醚的纳米包装 被引量:4

Nano Packaging of Artemether
下载PDF
导出
摘要 为克服蒿甲醚水溶性差,体内代谢快,生物利用度低的缺点,将其进行纳米包装.利用初生态微晶法,选用生物相容性好,可降解的明胶作为壁材,制备出了蒿甲醚纳米胶囊.电镜结果表明:纳米胶囊为分散均匀的球形纳米粒子.纳米胶囊的制备增强了蒿甲醚的水溶性.一定程度上拓展蒿甲醚临床应用的范围. Although artemether is a powerful drug used to treat malaria,there are some drawbacks because of its natural property such as insolubility in water,faster metabolism and lower bioavailability.In order to overcome these shortcomings,we prepared nanocapsules containing this drug by way of firstborn microcraystallization method were prepared.The products observed with transmission electron microscope(TEM) showed being the distributed spherical nanoparticles were well distributed.In this test gelatin was chose as the wall materials owing to its non-toxity,biocompatibility and biodegradability.The preparation of this nanocapsule could possibly expand the clinical application of artemether.
出处 《中南民族大学学报(自然科学版)》 CAS 2012年第1期55-57,共3页 Journal of South-Central University for Nationalities:Natural Science Edition
关键词 蒿甲醚 纳米胶囊 初生态微晶法 明胶 artemether nanocapsule firstborn microcrystallization method gelatin
  • 相关文献

参考文献7

二级参考文献31

共引文献31

同被引文献42

  • 1陈绍倩,王桂菊,姜中兴,孟晓丽,谢新生,王芳,孙慧,孙玲.羟基喜树碱联合阿糖胞苷和三尖杉酯碱治疗急性髓性白血病15例[J].白血病.淋巴瘤,2006,15(4):288-289. 被引量:1
  • 2洪宗国,童惠娟,钟益声.初生态微晶法制备纳米龙血竭微胶囊研究[J].化学与生物工程,2006,23(10):40-41. 被引量:6
  • 3叶孟,林蕾,方勇,潘宏铭,吴金民.羟基喜树碱通过激活NF-κB诱导人乳腺癌Bcap-37细胞凋亡[J].中国病理生理杂志,2007,23(1):146-150. 被引量:15
  • 4Pfeil J, Borrmann S, Tozan Y. Dihydroartemisinin-pipera quine versus artemether-lumefantrine for first-line treat ment of uncomplicated malaria in African children:a cost effectiveness analysis[J]. PLoS One, 2014,9 (4) : e95681.
  • 5Patil S,Joshi M, Pathak S, et al. Intravenous β-artemether formulation (ARM NLC) as a superior alternative to commercial artesunate formulation[J]. J Antimicrob Che- mother,2012,67 (11) :2713-2716.
  • 6Eltayeb SE, Su Z,Shi Y,et al. Preparation and optimiza- tion of transferrin-modified-artemether lipid nanospheres based on the orthogonal design of emulsion formulation and physically electrostatic adsorption[J]. Int J Pharm, 2013,452(1/2) :321-332.
  • 7Mandawgade SD, Sharma S, Pathak S,et al. Development of SMEDDS using natural lipophile: application to beta- Artemether delivery [J]. Int J Pharm, 2008, 362 (1/2) : 179-183.
  • 8Jain K, Gowthamarajan K, Sood S, et al. Olfactory drug delivery of artemether-cureumin combination for manage- ment of cerebral malaria[J]. Malar J, 2012,11 (Suppl 1 ) : 51.
  • 9Patil S, Suryavanshi S,Pathak S, et al. Evaluation of novel lipid based formulation of β-Artemether and Lumefantrine in murine malaria model[J]. Int J Pharm, 2013,455 ( 1/ 2) :229-234.
  • 10Golenser J, Waknine JH, Krugliak M, et al. Current per- spectives on the mechanism of action of artemisinins[J]. Int J Parasitol,2006,36(14):1427-1441.

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部